ArticleCureus2026
Secondary Postpartum Hemorrhage Following Vaginal Birth After Cesarean (VBAC) Successfully Managed With the JADA® System.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postpartum hemorrhage (PPH) remains a significant cause of maternal morbidity, most commonly resulting from uterine atony. Management typically follows a stepwise approach using uterotonics and mechanical interventions when bleeding persists. We report the case of a 25-year-old G8P4043 (eight pregnancies, four carried to term, 0 preterm deliveries, four abortions, and three living children) woman at 38 weeks and three days' gestation who underwent a successful vaginal birth after cesarean complicated by a 45-second shoulder dystocia. Initial quantitative blood loss was 300 mL with a firm uterus. Approximately two hours postpartum, the patient developed acute uterine atony with severe pain and heavy vaginal bleeding, resulting in a cumulative blood loss of 2,055 mL. Emergency bedside ultrasound demonstrated a markedly thickened endometrial stripe with a large intrauterine clot burden and minimal vascularity. Despite uterine massage, high-dose oxytocin, misoprostol, and repeated bimanual clot evacuation, the uterus remained boggy. Second-line uterotonics were deferred due to severe hypertension and a history of significant asthma. A vacuum-induced uterine hemorrhage control device, JADA® System (Organon & Co., Jersey City, NJ, USA), was placed following manual evacuation of intrauterine clots, resulting in rapid improvement in uterine tone and bleeding. The device was removed approximately five hours later without complication. Hemoglobin declined from 11.6 g/dL to a nadir of 8.3 g/dL, and no blood transfusion or surgical intervention was required. This case highlights the importance of early recognition, bedside ultrasound assessment, and timely escalation to mechanical therapy in the management of severe primary PPH, particularly in high-risk patients with contraindications to standard second-line uterotonic agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.